Sphingosine 1-Phosphate and Its Regulatory Role in Vascular Endothelial Cells

Investigators review the levels of S1P in those vascular and vascular-related diseases. Plasma S1P levels were reduced in various inflammation-related diseases such as atherosclerosis and sepsis, but were increased in other diseases including type 2 diabetes, neurodegeneration, and cerebrovascular damage.